US 11117945
T-cell modulatory multimeric polypeptides and methods of use thereof
granted A61KA61K2039/505A61K2039/55533
Quick answer
US patent 11117945 (T-cell modulatory multimeric polypeptides and methods of use thereof) held by Cue Biopharma, Inc. expires Mon Sep 09 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Cue Biopharma, Inc.
- Grant date
- Tue Sep 14 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 09 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 30
- CPC classes
- A61K, A61K2039/505, A61K2039/55533, A61K35/17, A61K38/00